Spotlight Stock,Trends & Articles Cyblin Inks Drug Development Agreement With Catalent For its Deuterated Tryptamine By Dennis Mutua March 23, 2021 Biotech company specializing on progressing psychedelic therapeutics Cybin Inc. (OTCMKTS: CLXPF) has inked a drug development agreement deal with New Jersey based Catalent Inc. (NYSE: CTLT) for its Deuterated Tryptamine (CYB003)....
Trends & Articles Revive Therapeutics Ltd. (OTCMKTS:RVVTF) Offers Update On Its Bucillamine Trial In COVID-19 Treatment By Larry Zweig March 22, 2021 Revive Therapeutics Ltd. (OTCMKTS:RVVTF) has announced an update on its US FDA third phase clinical study evaluating Bucillamine’s safety and efficacy in patients having mild-to moderated coronavirus. Revive expanding its Phase...
Psychedelic Stocks,Trends & Articles Cedar Picked to Partner with Merck on Trials of Treatment Resistant Depression Drug By Dennis Mutua March 19, 2021 Novamind Inc. (CNSX:NM)(OTC PINK:NVMDF) wholly owned subsidiary Cedar Clinical Research (CCR) has been selected to partner with leading pharmaceutical company Merck & Co Inc. (MRK) in clinical trial focusing on new treatment-...
Trends & Articles Psyched Wellness Submits Patent Application for Amanita Muscaria Extract AME-1 By Dennis Mutua March 18, 2021 Life science company Psyched Wellness Ltd (CNSX: PSYC) (OTCQB: PSYCF) announced having submitted a patent application in the United States Patent and Trademark office to cover the special extraction formula for its Amanita muscar...
Trends & Articles Entheon Biomedical Corp (OTCMKTS:ENTBF) Inks A Pact With Divergence Neuro Technologies Inc To Develop DMT Biomarkers By Larry Zweig February 25, 2021 Entheon Biomedical Corp (OTCMKTS:ENTBF) signed an agreement with Divergence Neuro Technologies Inc (DNT) for R&D of DMT (N, N-Dimethyltryptamine) biomarkers. They will also engage in the development of a predictive model of bi...
Trends & Articles COMPASS Pathways PLC (NASDAQ:CMPS) Partnering With World-Leading Scientists To Expand Its Discovery Center By Larry Zweig February 20, 2021 COMPASS Pathways PLC (NASDAQ:CMPS) is teaming up with a group of leading scientists to expand its Discovery Center. These scientists are affiliated to leading laboratories at Medical College of Wisconsin (MCW) and UC San Diego, Sc...
Trends & Articles Psychedelic Market Burgeoning Thanks To Acceptance For Psychedelic Therapies In Mental Disorders By Larry Zweig February 18, 2021 Over the past decade, the psychedelics drugs industry has grown in popularity in the US. In the past psychedelic were being used for mental healing practices but research stopped in the 1960s following the ban of psychedelics. How...
Trends & Articles Exploring Psychedelics As Potentially Viable Remedies For Trauma And Other Mental Health Conditions By Larry Zweig February 09, 2021 The mental health segment of the medical industry is currently going through a paradigm shift that is shedding light on psychedelics and their potential to deliver therapeutic relief against mental health conditions. Dr. Craig He...